CIP2A overexpression induces autoimmune response and enhances JNK signaling pathway in human lung cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CIP2A overexpression induces autoimmune response and enhances JNK signaling pathway in human lung cancer
Authors
Keywords
Tumor-associated antigen, Cancerous inhibitor of PP2A, c-Jun activated kinase (JNK), Mitogen activated kinase 4 (MKK4), Cell proliferation
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-11-11
DOI
10.1186/s12885-015-1899-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CIP2A regulates cancer metabolism and CREB phosphorylation in non-small cell lung cancer
- (2015) Bo Peng et al. Molecular BioSystems
- CIP2A Modulates Cell-Cycle Progression in Human Cancer Cells by Regulating the Stability and Activity of Plk1
- (2013) J.-S. Kim et al. CANCER RESEARCH
- Introduction to the Third Edition
- (2013) W. Michael Alberts CHEST
- Increased expression of CIP2A in aggressive subtypes of B-cell lymphoma
- (2013) Laura Lilja et al. HISTOPATHOLOGY
- Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) Protein Is Involved in Centrosome Separation through the Regulation of NIMA (Never In Mitosis Gene A)-related Kinase 2 (NEK2) Protein Activity
- (2013) Ae Lee Jeong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Using Immunoproteomics to Identify Alpha-enolase as an Autoantigen in Liver Fibrosis
- (2013) Bo Peng et al. JOURNAL OF PROTEOME RESEARCH
- Over-Expression of Cancerous Inhibitor of PP2A (CIP2A) in Bone Marrow Cells from Patients with a Group of High-Risk Myelodysplastic Syndromes
- (2013) Na Li et al. PATHOLOGY & ONCOLOGY RESEARCH
- Translational genomics: The challenge of developing cancer biomarkers
- (2012) J. D. Brooks GENOME RESEARCH
- CIP2A Is a Predictor of Poor Prognosis in Colon Cancer
- (2012) Hao-Wei Teng et al. JOURNAL OF GASTROINTESTINAL SURGERY
- CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma
- (2012) Yijun Xue et al. MEDICAL ONCOLOGY
- Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression
- (2011) C. M. Lucas et al. BLOOD
- Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients’ survival
- (2011) J Ren et al. BRITISH JOURNAL OF CANCER
- Bortezomib Sensitizes HCC Cells to CS-1008, an Antihuman Death Receptor 5 Antibody, through the Inhibition of CIP2A
- (2011) K.-F. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors
- (2010) Jian-Ying Zhang et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- CIP2A expression is increased in prostate cancer
- (2010) Markku H Vaarala et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CIP2A is overexpressed in esophageal squamous cell carcinoma
- (2010) Wei Qu et al. MEDICAL ONCOLOGY
- CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells
- (2010) K-F Chen et al. ONCOGENE
- Autoantibodies to tumor-associated antigens: reporters from the immune system
- (2008) Eng M. Tan et al. IMMUNOLOGICAL REVIEWS
- Using Proteomic Approach to Identify Tumor-Associated Antigens as Markers in Hepatocellular Carcinoma
- (2008) Kok Sun Looi et al. JOURNAL OF PROTEOME RESEARCH
- Multiple pathways regulated by the tumor suppressor PP2A in transformation
- (2008) Jukka Westermarck et al. TRENDS IN MOLECULAR MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now